3 not yet recruiting, 1 completed, 1 recruiting, 1 withdrawn. 3 Phase 2, 2 Not applicable, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Withdrawn 1 |
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
Follow HPV Associated Cancers: new trials by email Literature Review of HPV Associated Cancers trials Research Report on HPV Associated Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 35 | 2026-08-31 | 2026-07-08 |
| Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers | Not applicable | Not yet recruiting | University of California, San Diego | 750 | 2026-06-01 | 2026-05-08 |
| CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV PDS0101 - HPV Associated Cancers, HIV (Human Immunodeficiency Virus) | Phase 2 | Withdrawn | University of California, San Diego | 2026-04-30 | 2026-08-19 | |
| Emergency Department-based Cervical Cancer Screening Through Self-sampling Cervical Cancer Screening - HPV, HPV Associated Cancers | Not applicable | Recruiting | University of Rochester | 200 | 2026-02-13 | 2026-05-04 |
| Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma de-intensified radiation - OPSCC, Oropharyngeal Squamous Cell Carcinoma (SCC) | Phase 2 | Not yet recruiting | University of Vermont Medical Center | 20 | 2025-01-01 | 2025-01-06 |
| Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer TGN-S11, Pembrolizumab - HPV Associated Cancers | Phase 1 | Completed | Toragen, Inc. | 28 | 2023-06-20 | 2025-09-09 |
Uterine Cervical Neoplasms (3) · Acquired Immunodeficiency Syndrome (2) · Anus Neoplasms (1) · Carcinoma, Squamous Cell (1) · Papillomavirus Infections (1) · Squamous Cell Carcinoma of Head and Neck (1) · Uterine Cervical Dysplasia (1)
Neoplasms (5) · Genital Diseases (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Communicable Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Infections (3) · Sexually Transmitted Diseases (3) · Sexually Transmitted Diseases, Viral (3) · Urogenital Neoplasms (3) · Uterine Cervical Diseases (3) · Uterine Diseases (3)
Acetic Acid (1) · Radiosurgery (1) · Transurethral Resection of Prostate (1) · Watchful Waiting (1) · pembrolizumab (1)
University of California, San Diego (2) · Abramson Cancer Center at Penn Medicine (1) · Toragen, Inc. (1) · University of Rochester (1) · University of Vermont Medical Center (1)
United States (3) · Botswana (1) · Puerto Rico (1)
Neil J Clendeninn, MD, PhD (1) · Timothy J Wilkin, MD, MPH (1) · Timothy Wilkin, MD, MPH (1)
U24CA275417 (2), UG1CA275414 (2), UG1CA275416 (1), UG1CA284883 (1), UG1CA284884 (1)